LY3325656
LY3325656 is a GPR142 agonist with demonstrated anti-diabetic efficacy in preclinical models, showing suitable ADME/PK for human use. It is the first molecule of its class to enter Phase 1 clinical trials for Type 2 diabetes, following studies confirming its in vitro receptor activation and in vivo glucose-lowering effects in animal studies.
Product Specifications
CAS Number
1998714-25-2
Smiles
CC1=C (N (C) C=N1) C=2NC (=NN2) [C@@H]3C[C@H] (N (C (=O) C4=CC (C (F) (F) F) =CC=C4) C) CCO3
Molecular Formula
C21H23F3N6O2
Molecular Weight
448.44
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
QY-E10148 96 Tests
Rat Signal Transducer And Activator Of Transcription 3 (STAT3) ELISA kit
Sign In for Pricing
View Details 
TL706928V 500 µL Each
Ndfip2 Rat shRNA Lentiviral Particle (Locus ID 361089)
Sign In for Pricing
View Details